Merritt TA - Search Results

1

Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome.

Cochrane CG, Revak SD, Merritt TA, Schraufstätter IU, Hoch RC, Henderson C, Andersson S, Takamori H, Oades ZG. Cochrane CG, et al. Among authors: merritt ta. Pediatr Res. 1998 Nov;44(5):705-15. doi: 10.1203/00006450-199811000-00013. Pediatr Res. 1998. PMID: 9803452

2

Positive end-expiratory pressure during KL4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome.

Merritt TA, Kheiter A, Cochrane CG. Merritt TA, et al. Pediatr Res. 1995 Aug;38(2):211-7. doi: 10.1203/00006450-199508000-00013. Pediatr Res. 1995. PMID: 7478818

3

The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome.

Cochrane CG, Revak SD, Merritt TA, Heldt GP, Hallman M, Cunningham MD, Easa D, Pramanik A, Edwards DK, Alberts MS. Cochrane CG, et al. Among authors: merritt ta. Am J Respir Crit Care Med. 1996 Jan;153(1):404-10. doi: 10.1164/ajrccm.153.1.8542150. Am J Respir Crit Care Med. 1996. PMID: 8542150

4

Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.

Manalo E, Merritt TA, Kheiter A, Amirkhanian J, Cochrane C. Manalo E, et al. Among authors: merritt ta. Pediatr Res. 1996 Jun;39(6):947-52. doi: 10.1203/00006450-199606000-00004. Pediatr Res. 1996. PMID: 8725253

5

Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys.

Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW, Kheiter A. Revak SD, et al. Among authors: merritt ta. Pediatr Res. 1996 Apr;39(4 Pt 1):715-24. doi: 10.1203/00006450-199604000-00025. Pediatr Res. 1996. PMID: 8848350

6

The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.

Revak SD, Merritt TA, Hallman M, Heldt G, La Polla RJ, Hoey K, Houghten RA, Cochrane CG. Revak SD, et al. Among authors: merritt ta. Pediatr Res. 1991 May;29(5):460-5. doi: 10.1203/00006450-199105010-00010. Pediatr Res. 1991. PMID: 1896249

7

Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.

Revak SD, Merritt TA, Degryse E, Stefani L, Courtney M, Hallman M, Cochrane CG. Revak SD, et al. Among authors: merritt ta. J Clin Invest. 1988 Mar;81(3):826-33. doi: 10.1172/JCI113391. J Clin Invest. 1988. PMID: 3343343 Free PMC article.

8

A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome.

Wiswell TE, Knight GR, Finer NN, Donn SM, Desai H, Walsh WF, Sekar KC, Bernstein G, Keszler M, Visser VE, Merritt TA, Mannino FL, Mastrioianni L, Marcy B, Revak SD, Tsai H, Cochrane CG. Wiswell TE, et al. Among authors: merritt ta. Pediatrics. 2002 Jun;109(6):1081-7. doi: 10.1542/peds.109.6.1081. Pediatrics. 2002. PMID: 12042546 Clinical Trial.

9

Human surfactant treatment of severe respiratory distress syndrome: pulmonary effluent indicators of lung inflammation.

Merritt TA, Hallman M, Holcomb K, Strayer D, Bloom B, Revak S, Cochrane CG. Merritt TA, et al. J Pediatr. 1986 May;108(5 Pt 1):741-8. doi: 10.1016/s0022-3476(86)81058-7. J Pediatr. 1986. PMID: 3486264 Clinical Trial.

10

Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo.

Revak SD, Merritt TA, Hallman M, Cochrane CG. Revak SD, et al. Among authors: merritt ta. Am Rev Respir Dis. 1986 Dec;134(6):1258-65. doi: 10.1164/arrd.1986.134.5.1258. Am Rev Respir Dis. 1986. PMID: 3789526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page